The Latest Breaking News from AMEX

Friday Is Your Last Chance To Buy Allspring Multi-Sector Before The Dividend Payout

Friday marks the last chance for investors to receive the next dividend payout from Allspring Multi-Sector (AMEX:ERC).

Benzinga · Apr 6, 2022

Milestone Scientific Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q4, Milestone Scientific (AMEX:MLSS) posted sales of $2.85 million. Earnings were up 44.62%, but Milestone Scientific still reported an overall loss of $1.14 million.

Benzinga · Apr 4, 2022

Protalix BioTherapeutics's Return On Capital Employed Insights

Benzinga Pro data, Protalix BioTherapeutics (AMEX:PLX) reported Q4 sales of $8.55 million. Earnings fell to a loss of $6.67 million, resulting in a 58.78% decrease from last quarter.

Benzinga · Apr 1, 2022

Why Is KULR Technology Group Stock Surging Today?

KULR Technology Group Inc (AMEX:KULR) shares are trading higher Thursday morning after the company announced it secured a contract with NASA to test lithium-ion cells going into future battery packs designed for the Artemis Program.

Benzinga · Mar 31, 2022

Recap: Protalix BioTherapeutics Q4 Earnings

  Protalix BioTherapeutics (AMEX:PLX) reported its Q4 earnings results on Thursday, March 31, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 31, 2022

Earnings Outlook For Protalix BioTherapeutics

Protalix BioTherapeutics (AMEX:PLX) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Protalix BioTherapeutics will report an earnings per share (EPS) of $-0.11.

Benzinga · Mar 30, 2022

NovaBay Pharmaceuticals's Return On Capital Employed Insights

According to Benzinga Pro data, during Q4, NovaBay Pharmaceuticals (AMEX:NBY) posted sales of $2.64 million. Earnings were up 93.1%, but NovaBay Pharmaceuticals still reported an overall loss of $158.00 thousand.

Benzinga · Mar 30, 2022

Earnings Preview For Ampio Pharmaceuticals

Ampio Pharmaceuticals (AMEX:AMPE) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Ampio Pharmaceuticals will report an earnings per share (EPS) of $-0.02.

Benzinga · Mar 28, 2022

NovaBay Pharmaceuticals Earnings Preview

NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that NovaBay Pharmaceuticals will report an earnings per share (EPS) of $-0.05.

Benzinga · Mar 28, 2022

Acme United's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Acme United (AMEX:ACU).

Benzinga · Mar 28, 2022